Litigation Details for Alvotech USA Inc. v. Abbvie Inc (E.D. Va. 2021)
✉ Email this page to a colleague
Alvotech USA Inc. v. Abbvie Inc (E.D. Va. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-05-11 |
Court | District Court, E.D. Virginia | Date Terminated | 2021-05-12 |
Cause | 28:2201 Declaratory Judgment | Assigned To | |
Jury Demand | Plaintiff | Referred To | |
Patents | 8,420,081; 8,889,136; 8,926,975; 8,961,973; 9,067,992; 9,085,619; 9,090,689 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Alvotech USA Inc. v. Abbvie Inc
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Alvotech USA Inc. v. Abbvie Inc (E.D. Va. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-05-11 | 1 | THE PATENTS-IN-SUIT U.S. Patent No. 8,420,081 78.…78. U.S. Patent No. 8,420,081 (“the ’081 patent”), titled “Antibody Formulations and Methods of Making…the way for market entry of AVT02: U.S. Patent Nos. 8,420,081; 9,085,619; 8,926,975; and 8,961,973. …Declaratory Judgment of Non-infringement of U.S. Patent No. 8,420,081) 82. Plaintiffs re-allege the…Declaratory Judgment of Invalidity of U.S. Patent No. 8,420,081) 87. Plaintiffs re-allege | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |